The evolution of the cancer stem cell state in glioblastoma: emerging insights into the next generation of functional interactions
- PMID: 33173943
- PMCID: PMC7906055
- DOI: 10.1093/neuonc/noaa259
The evolution of the cancer stem cell state in glioblastoma: emerging insights into the next generation of functional interactions
Abstract
Cellular heterogeneity is a hallmark of advanced cancers and has been ascribed in part to a population of self-renewing, therapeutically resistant cancer stem cells (CSCs). Glioblastoma (GBM), the most common primary malignant brain tumor, has served as a platform for the study of CSCs. In addition to illustrating the complexities of CSC biology, these investigations have led to a deeper understanding of GBM pathogenesis, revealed novel therapeutic targets, and driven innovation towards the development of next-generation therapies. While there continues to be an expansion in our knowledge of how CSCs contribute to GBM progression, opportunities have emerged to revisit this conceptual framework. In this review, we will summarize the current state of CSCs in GBM using key concepts of evolution as a paradigm (variation, inheritance, selection, and time) to describe how the CSC state is subject to alterations of cell intrinsic and extrinsic interactions that shape their evolutionarily trajectory. We identify emerging areas for future consideration, including appreciating CSCs as a cell state that is subject to plasticity, as opposed to a discrete population. These future considerations will not only have an impact on our understanding of this ever-expanding field but will also provide an opportunity to inform future therapies to effectively treat this complex and devastating disease.
Keywords: cancer stem cell; glioblastoma; review; stem cell state.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Figures
![Fig. 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7906055/bin/noaa259_fig1.gif)
![Fig. 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7906055/bin/noaa259_fig2.gif)
![Fig. 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7906055/bin/noaa259_fig3.gif)
![Fig. 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7906055/bin/noaa259_fig4.gif)
Similar articles
-
Cancer stem cell hypothesis 2.0 in glioblastoma: Where are we now and where are we going?Neuro Oncol. 2024 May 3;26(5):785-795. doi: 10.1093/neuonc/noae011. Neuro Oncol. 2024. PMID: 38394444 Review.
-
Unexplored Functions of Sex Hormones in Glioblastoma Cancer Stem Cells.Endocrinology. 2022 Mar 1;163(3):bqac002. doi: 10.1210/endocr/bqac002. Endocrinology. 2022. PMID: 35023543 Free PMC article. Review.
-
Identifying conserved molecular targets required for cell migration of glioblastoma cancer stem cells.Cell Death Dis. 2020 Feb 26;11(2):152. doi: 10.1038/s41419-020-2342-2. Cell Death Dis. 2020. PMID: 32102991 Free PMC article.
-
Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.J Chin Med Assoc. 2016 Oct;79(10):538-45. doi: 10.1016/j.jcma.2016.03.010. Epub 2016 Aug 13. J Chin Med Assoc. 2016. PMID: 27530866
-
Cancer stem cells in glioblastoma.Genes Dev. 2015 Jun 15;29(12):1203-17. doi: 10.1101/gad.261982.115. Genes Dev. 2015. PMID: 26109046 Free PMC article. Review.
Cited by
-
Homeostatic iron regulatory protein drives glioblastoma growth via tumor cell-intrinsic and sex-specific responses.Neurooncol Adv. 2023 Nov 28;6(1):vdad154. doi: 10.1093/noajnl/vdad154. eCollection 2024 Jan-Dec. Neurooncol Adv. 2023. PMID: 38239626 Free PMC article.
-
Hypoxia-induced galectin-8 maintains stemness in glioma stem cells via autophagy regulation.Neuro Oncol. 2024 May 3;26(5):872-888. doi: 10.1093/neuonc/noad264. Neuro Oncol. 2024. PMID: 38158714
-
Glioblastoma pseudoprogression and true progression reveal spatially variable transcriptional differences.Acta Neuropathol Commun. 2023 Dec 4;11(1):192. doi: 10.1186/s40478-023-01587-w. Acta Neuropathol Commun. 2023. PMID: 38049893 Free PMC article.
-
The tumor-enriched small molecule gambogic amide suppresses glioma by targeting WDR1-dependent cytoskeleton remodeling.Signal Transduct Target Ther. 2023 Nov 8;8(1):424. doi: 10.1038/s41392-023-01666-3. Signal Transduct Target Ther. 2023. PMID: 37935665 Free PMC article.
-
The STEMRI trial: Magnetic resonance spectroscopy imaging can define tumor areas enriched in glioblastoma stem-like cells.Sci Adv. 2023 Nov 3;9(44):eadi0114. doi: 10.1126/sciadv.adi0114. Epub 2023 Nov 3. Sci Adv. 2023. PMID: 37922359 Free PMC article. Clinical Trial.
References
-
- Galli R, Binda E, Orfanelli U, et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 2004;64(19):7011–7021. - PubMed
-
- Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature. 2004;432(7015):396–401. - PubMed
-
- Bao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006;444(7120):756–760. - PubMed